ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 77 filers reported holding ONCOCYTE CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,374,000 | -46.2% | 1,882,768 | -33.7% | 0.03% | -43.5% |
| Q2 2022 | $2,553,000 | -51.0% | 2,837,800 | -18.8% | 0.05% | -45.2% |
| Q1 2022 | $5,206,000 | -31.3% | 3,493,800 | 0.0% | 0.08% | -13.4% |
| Q4 2021 | $7,582,000 | -25.4% | 3,493,800 | +22.3% | 0.10% | -13.4% |
| Q3 2021 | $10,167,000 | -15.7% | 2,856,000 | +36.0% | 0.11% | -8.2% |
| Q2 2021 | $12,054,000 | +10.6% | 2,100,000 | 0.0% | 0.12% | +19.6% |
| Q1 2021 | $10,899,000 | – | 2,100,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 719,282 | $2,359,245 | 0.35% |
| Defender Capital, LLC. | 114,520 | $357,302 | 0.13% |